Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Proteinaceous is a biotechnology company focused on advancing the field of top-down proteomics through specialized software and analytical tools. The company's flagship products, including the Proteoform Suite and Proteoform Explorer, enable researchers to identify and characterize proteoforms—the specific molecular forms of proteins—with high precision using mass spectrometry data. By providing a comprehensive platform for proteoform-level analysis, Proteinaceous helps scientists in academia and the pharmaceutical industry better understand protein variation and its role in disease. The company was founded by leaders in the field of top-down proteomics from Northwestern University. Its solutions are designed to bridge the gap between complex mass spectrometry data and biological insight.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Proteinaceous.